We are live on
!
Find out more
NanoViricides
NNVC
NNVC
31 hedge funds and large institutions have $2.3M invested in NanoViricides in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
310% more call options, than puts
Call options by funds: $516K | Put options by funds: $126K
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
24% more funds holding
Funds holding: 25 → 31 (+6)
10% more capital invested
Capital invested by funds: $2.09M → $2.3M (+$207K)
1.87% more ownership
Funds ownership: 9.65% → 11.52% (+1.9%)
Holders
31
Holders Change
+6
Holders Change %
+24%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
5
Reduced
4
Closed
3
Calls
$516K
Puts
$126K
Net Calls
+$390K
Net Calls Change
+$355K
Top Buyers
| 1 |
Millennium Management
New York
|
+$92.3K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$78.2K |
| 3 |
Two Sigma Investments
New York
|
+$74.6K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$65.8K |
| 5 |
Morgan Stanley
New York
|
+$51.6K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$11.4K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$2.18K |
| 4 |
CG
Cutler Group
San Francisco,
California
|
-$2K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$1.09K |
